Rosenstock, J., Hsia, S., Ruiz, L. N., Eyde, S., Cox, D., Wu, W., Liu, R., Li, J., Landó, L. F., Denning, M., Ludwig, L., Chen, Y. (2025). Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2505669